|
Chinook Therapeutics
|
5.7 |
$13M |
|
14k |
902.81 |
|
Spdr Ser Tr S&p Biotech Call Option
(XBI)
|
5.7 |
$13M |
|
94k |
135.40 |
|
Dicerna Pharmaceuticals
|
3.8 |
$8.6M |
|
230k |
37.32 |
|
Merus N V
(MRUS)
|
3.0 |
$6.8M |
|
321k |
21.07 |
|
Mirati Therapeutics
|
2.7 |
$6.1M |
|
38k |
161.52 |
|
Veracyte
(VCYT)
|
2.7 |
$6.0M |
|
151k |
39.98 |
|
Morphic Hldg
(MORF)
|
2.7 |
$6.0M |
|
104k |
57.39 |
|
Amryt Pharma Sponsored Ads
|
2.5 |
$5.5M |
|
457k |
12.13 |
|
Biohaven Pharmaceutical Holding
|
2.5 |
$5.5M |
|
57k |
97.08 |
|
ImmunoGen
|
2.4 |
$5.5M |
|
828k |
6.59 |
|
Insmed Com Par $.01
(INSM)
|
2.3 |
$5.0M |
|
177k |
28.46 |
|
Research Alliance Corp Ii Com Cl A
|
2.2 |
$5.0M |
|
496k |
10.14 |
|
Macrogenics
(MGNX)
|
2.1 |
$4.8M |
|
177k |
26.86 |
|
Horizon Therapeutics Pub L SHS
|
2.1 |
$4.7M |
|
50k |
93.63 |
|
Intra Cellular Therapies
(ITCI)
|
2.1 |
$4.6M |
|
113k |
40.82 |
|
Seres Therapeutics Call Option
|
2.0 |
$4.5M |
|
187k |
23.85 |
|
Verastem
|
1.9 |
$4.3M |
|
1.0M |
4.07 |
|
Renalytix Ads
(RNLXY)
|
1.7 |
$3.9M |
|
126k |
30.86 |
|
Eloxx Pharmaceuticals
|
1.7 |
$3.8M |
|
1.9M |
1.99 |
|
Medicus Sciences Acquisition Cl A Shs
|
1.6 |
$3.6M |
|
373k |
9.65 |
|
Immatics SHS
(IMTX)
|
1.5 |
$3.4M |
|
289k |
11.61 |
|
Aclaris Therapeutics
(ACRS)
|
1.5 |
$3.3M |
|
189k |
17.56 |
|
Tcr2 Therapeutics Inc cs
|
1.4 |
$3.1M |
|
188k |
16.41 |
|
Halozyme Therapeutics
(HALO)
|
1.4 |
$3.0M |
|
67k |
45.42 |
|
Stereotaxis Com New
(STXS)
|
1.3 |
$3.0M |
|
306k |
9.64 |
|
Celldex Therapeutics Com New
(CLDX)
|
1.3 |
$2.9M |
|
9.9k |
294.93 |
|
Adamas Pharmaceuticals
|
1.3 |
$2.8M |
|
539k |
5.28 |
|
United Therapeutics Corporation
(UTHR)
|
1.2 |
$2.7M |
|
15k |
179.41 |
|
Sierra Oncology Com New
|
1.2 |
$2.7M |
|
139k |
19.47 |
|
Social Cap Suvretta Hlds Crp Class A Ord Shs
|
1.1 |
$2.5M |
|
250k |
10.12 |
|
Social Cap Suvretta Hlds Crp Class A Ord Shs
|
1.1 |
$2.5M |
|
250k |
10.11 |
|
Social Cap Suvretta Hld Crpi Class A Ord Shs
|
1.1 |
$2.5M |
|
250k |
10.11 |
|
Social Cap Suvretta Hlds Cp Class A Ord Shs
|
1.1 |
$2.5M |
|
250k |
10.10 |
|
Helix Acquisition Corp Com Cl A
|
1.1 |
$2.4M |
|
234k |
10.35 |
|
Nextcure
(NXTC)
|
1.0 |
$2.3M |
|
286k |
8.03 |
|
Aldeyra Therapeutics
(ALDX)
|
1.0 |
$2.2M |
|
192k |
11.33 |
|
Eyepoint Pharmaceuticals Com New
(EYPT)
|
1.0 |
$2.2M |
|
242k |
8.99 |
|
Otonomy
|
0.9 |
$2.1M |
|
953k |
2.23 |
|
Curis Com New
|
0.9 |
$2.1M |
|
260k |
8.07 |
|
Benitec Biopharma
|
0.9 |
$2.0M |
|
467k |
4.25 |
|
Cullinan Oncology
(CGEM)
|
0.9 |
$2.0M |
|
76k |
25.75 |
|
Vistagen Therapeutics Com New
|
0.9 |
$1.9M |
|
616k |
3.15 |
|
Iteos Therapeutics
|
0.9 |
$1.9M |
|
76k |
25.65 |
|
Zentalis Pharmaceuticals
(ZNTL)
|
0.8 |
$1.8M |
|
35k |
53.19 |
|
Compugen Ord
(CGEN)
|
0.8 |
$1.7M |
|
209k |
8.28 |
|
Kura Oncology
(KURA)
|
0.8 |
$1.7M |
|
83k |
20.85 |
|
Affimed Therapeutics B V
|
0.8 |
$1.7M |
|
202k |
8.50 |
|
Jounce Therapeutics
|
0.8 |
$1.7M |
|
251k |
6.80 |
|
Mersana Therapeutics
|
0.8 |
$1.7M |
|
125k |
13.58 |
|
Arcus Biosciences Incorporated Put Option
(RCUS)
|
0.7 |
$1.7M |
|
60k |
27.47 |
|
Cerevel Therapeutics Hldng I
(CERE)
|
0.7 |
$1.7M |
|
15k |
110.60 |
|
Cogent Biosciences
(COGT)
|
0.7 |
$1.6M |
|
198k |
8.11 |
|
Cyclacel Pharmaceuticals
|
0.7 |
$1.5M |
|
258k |
5.92 |
|
Rapt Therapeutics
|
0.7 |
$1.5M |
|
47k |
31.78 |
|
Relmada Therapeutics
(RLMD)
|
0.7 |
$1.5M |
|
47k |
32.01 |
|
Arena Pharmaceuticals Com New
|
0.6 |
$1.4M |
|
21k |
68.18 |
|
Polypid SHS
|
0.6 |
$1.4M |
|
155k |
9.06 |
|
Deciphera Pharmaceuticals
|
0.6 |
$1.4M |
|
37k |
36.61 |
|
Chemocentryx Put Option
|
0.6 |
$1.3M |
|
100k |
13.39 |
|
Reata Pharmaceuticals Cl A
|
0.6 |
$1.3M |
|
9.3k |
141.56 |
|
Mereo Biopharma Group Ads
(MREO)
|
0.6 |
$1.3M |
|
406k |
3.17 |
|
Delcath Sys Com New
(DCTH)
|
0.6 |
$1.3M |
|
99k |
12.61 |
|
Evogene SHS
|
0.6 |
$1.2M |
|
361k |
3.42 |
|
Athira Pharma
(ATHA)
|
0.5 |
$1.2M |
|
118k |
10.24 |
|
Trillium Therapeutics Com New
|
0.4 |
$923k |
|
95k |
9.70 |
|
Seagen
|
0.4 |
$905k |
|
5.7k |
157.89 |
|
Wave Life Sciences SHS
(WVE)
|
0.4 |
$826k |
|
124k |
6.66 |
|
Akero Therapeutics
(AKRO)
|
0.4 |
$819k |
|
33k |
24.80 |
|
Ardelyx
(ARDX)
|
0.3 |
$752k |
|
99k |
7.58 |
|
Ascendis Pharma A/s Sponsored Adr
(ASND)
|
0.3 |
$737k |
|
5.6k |
131.63 |
|
Surface Oncology
|
0.3 |
$705k |
|
95k |
7.46 |
|
Bellus Health Com New
|
0.3 |
$653k |
|
210k |
3.11 |
|
Odonate Therapeutics Ord
|
0.3 |
$652k |
|
187k |
3.49 |
|
Viewray
(VRAYQ)
|
0.3 |
$623k |
|
94k |
6.60 |
|
Syndax Pharmaceuticals
(SNDX)
|
0.3 |
$596k |
|
35k |
17.16 |
|
Guardant Health
(GH)
|
0.3 |
$580k |
|
4.7k |
124.12 |
|
Cerus Corporation
(CERS)
|
0.2 |
$528k |
|
19k |
28.25 |
|
Sage Therapeutics Call Option
(SAGE)
|
0.2 |
$528k |
|
9.3k |
56.77 |
|
89bio
(ETNB)
|
0.2 |
$524k |
|
28k |
18.69 |
|
Miragen Therapeutics
(VRDN)
|
0.2 |
$519k |
|
28k |
18.28 |
|
Salarius Pharmaceuticals Com New
|
0.2 |
$500k |
|
472k |
1.06 |
|
Rocket Pharmaceuticals
(RCKT)
|
0.2 |
$456k |
|
10k |
44.30 |
|
Apellis Pharmaceuticals
(APLS)
|
0.2 |
$443k |
|
7.0k |
63.20 |
|
Catabasis Pharmaceuticals In Com New
|
0.2 |
$398k |
|
189k |
2.11 |
|
Kalvista Pharmaceuticals
(KALV)
|
0.2 |
$357k |
|
15k |
23.99 |
|
Medicenna Therapeutics Corp.
(MDNAF)
|
0.1 |
$333k |
|
111k |
3.01 |
|
Uniqure Nv SHS
(QURE)
|
0.1 |
$288k |
|
9.3k |
30.82 |
|
Madrigal Pharmaceuticals
(MDGL)
|
0.1 |
$242k |
|
2.5k |
97.58 |
|
Forma Therapeutics Hldgs SHS
|
0.1 |
$241k |
|
9.7k |
24.90 |
|
Ayala Pharmaceuticals Incorporated
|
0.1 |
$238k |
|
23k |
10.19 |
|
Eton Pharmaceuticals
(ETON)
|
0.1 |
$115k |
|
19k |
6.15 |
|
Chardan Healthcr Acqstn 2 *w Exp 03/05/202
|
0.0 |
$85k |
|
105k |
0.81 |
|
Chardan Healthcare Acqu- Ord
|
0.0 |
$78k |
|
14k |
5.49 |
|
Calithera Biosciences
|
0.0 |
$66k |
|
31k |
2.10 |
|
Medicus Sciences Acquisition *w Exp 02/12/202
|
0.0 |
$50k |
|
50k |
1.00 |